{
  "id": 1942,
  "text": "1703</td><td>2004</td><td>14</td><td>Cisplatin/bryostatin-1</td><td>0</td><td>nr</td></tr><tr><td>Maluf et al.1707</td><td>2006</td><td>36</td><td>Cisplatin/tirapazamine</td><td>27.8</td><td>nr</td></tr><tr><td>Takekuma et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1703</td><td>2004</td><td>14</td><td>Cisplatin/bryostatin-1</td><td>0</td><td>nr</td></tr><tr><td>Maluf et al.1707</td><td>2006</td><td>36</td><td>Cisplatin/tirapazamine</td><td>27.8</td><td>nr</td></tr><tr><td>Takekuma et al.\n\n<question>: ",
  "ChatGPT_response_0": "\"Maluf et al.1707\"研究中使用的治疗方案是Cisplatin/tirapazamine。这种治疗方案结合了顺铂（Cisplatin）和替拉帕替明（Tirapazamine）等药物，这在一些研究中显示出潜在的治疗效果。顺铂是一种常用的化疗药物，而替拉帕替明则可能对肿瘤细胞产生更特异的效应。这种联合治疗方案的使用可能有助于提高治疗效果及降低副作用发生的风险。\"",
  "query": "什么是在\"Maluf et al.1707\"研究中使用的治疗方案？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么是在\"Maluf et al.1707\"研究中使用的治疗方案？\n\n<reference text>: 1703</td><td>2004</td><td>14</td><td>Cisplatin/bryostatin-1</td><td>0</td><td>nr</td></tr><tr><td>Maluf et al.1707</td><td>2006</td><td>36</td><td>Cisplatin/tirapazamine</td><td>27.8</td><td>nr</td></tr><tr><td>Takekuma et al.\n\n<reply>: ",
  "response": "\"Maluf et al.1707\"研究中使用的治疗方案是Cisplatin/tirapazamine。这种治疗方案结合了顺铂（Cisplatin）和替拉帕替明（Tirapazamine）等药物，这在一些研究中显示出潜在的治疗效果。顺铂是一种常用的化疗药物，而替拉帕替明则可能对肿瘤细胞产生更特异的效应。这种联合治疗方案的使用可能有助于提高治疗效果及降低副作用发生的风险。\""
}